Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ginwa Enterprise GroupSHSE:600080 +2.57%46 EV-to-EBITDA is 56.33 as of Aug. 20, 2026, which is 22% above its 10-year median of 46.06. GuruFocus rates SHSE:600080 with a GF Score™ of 46/100 and a GF Value™ of ¥7.53 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 736 Drug Manufacturers companies, Ginwa Enterprise Group ranks worse than 90.22% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ginwa Enterprise Group's enterprise value is ¥1,468.4 Mil.
Ginwa Enterprise Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ¥26.1 Mil. Therefore, Ginwa Enterprise Group's EV-to-EBITDA for today is 56.33.
The historical rank and industry rank for Ginwa Enterprise Group's EV-to-EBITDA or its related term are showing as below:
SHSE:600080'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -373.43 Med: 46.06 Max: 156.53
Current: 59.77
During the past 13 years, the highest EV-to-EBITDA of Ginwa Enterprise Group was 156.53. The lowest was -373.43. And the median was 46.06.
SHSE:600080's EV-to-EBITDA is ranked worse than 90.22% of 736
companies
in the Drug Manufacturers industry
Industry Median: 13.305
vs SHSE:600080: 59.77
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ginwa Enterprise Group (SHSE:600080) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ginwa Enterprise Group's PE Ratio (TTM) for today is calculated as:
Ginwa Enterprise Group's share price for today is ¥4.79.
Ginwa Enterprise Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.051.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ginwa Enterprise Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ginwa Enterprise Group EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ginwa Enterprise Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ginwa Enterprise Group's EV-to-EBITDA falls into.
Ginwa Enterprise Group's current Enterprise Value is ¥1,468.4 Mil.
Ginwa Enterprise Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥26.1 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ginwa Enterprise Group (SHSE:600080) has a EV-to-EBITDA of 56.33 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ginwa Enterprise Group. This is 22% above median its historical median of 46.06. According to the industry distribution chart, Ginwa Enterprise Group ranks #664 out of 736 companies in the Drug Manufacturers industry, placing it in the top 90.2%.
Is Ginwa Enterprise Group's EV-to-EBITDA too high?
Ginwa Enterprise Group's current EV-to-EBITDA of 56.33 is 22% above median its 10-year median of 46.06. The Drug Manufacturers industry median EV-to-EBITDA is 13.31. Ginwa Enterprise Group's value of 56.33 is 323.4% above this industry median. Based on the distribution chart, Ginwa Enterprise Group ranks #664 out of 736 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Ginwa Enterprise Group has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Ginwa Enterprise Group's EV-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Ginwa Enterprise Group ranks #664 out of 736 companies for EV-to-EBITDA. This places Ginwa Enterprise Group in the lower half of its industry. The industry median EV-to-EBITDA is 13.31. Ginwa Enterprise Group's value of 56.33 is 323.4% above this benchmark. While the company's 10-year median is 46.06 vs. the industry median of 13.31, Ginwa Enterprise Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 13.31, based on 736 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ginwa Enterprise Group's current EV-to-EBITDA of 56.33 is 323.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ginwa Enterprise Group. For the Drug Manufacturers industry, the median EV-to-EBITDA is 13.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ginwa Enterprise Group's current EV-to-EBITDA is 56.33, which is 22% above median its own 10-year median of 46.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginwa Enterprise Group stock overvalued right now?
Based on GuruFocus' analysis, Ginwa Enterprise Group (SHSE:600080) is currently considered Possible Value Trap. The stock's GF Value™ is ¥7.53, compared to a current price of ¥4.79 — trading 36.4% below its estimated fair value. The current EV-to-EBITDA is 56.33, which is 22% above median its 10-year median of 46.06 and 323.4% above the Drug Manufacturers industry median of 13.31. Ginwa Enterprise Group's overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ginwa Enterprise Group (SHSE:600080), the current EV-to-EBITDA is 56.33 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ginwa Enterprise Group (SHSE:600080) Overvalued in 2026?
Based on GuruFocus' analysis, Ginwa Enterprise Group stock appears to be undervalued.
The current stock price of ¥4.79 is trading 36.4% below its estimated GF Value™ of ¥7.53.
GuruFocus considers Ginwa Enterprise Group to be Possible Value Trap.
Key valuation signals for SHSE:600080:
EV-to-EBITDA: 56.33 (22% above median its 10-year median of 46.06)
GF Value™: ¥7.53 vs. price of ¥4.79 (36.4% below fair value)
Industry Position: 323.4% above the Drug Manufacturers median (#664 of 736)
No single metric tells the full story. See the SHSE:600080 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ginwa Enterprise Group Inc operates in the pharmaceutical industry. The main business is the research and development, production, and sales of drugs, and the product line covers chemical drugs, Chinese patent medicines, raw materials, and health products. The dosage forms include tablets, capsules, granules, powders, mixtures, oral solutions, syrups, external solutions, and more than 100 varieties and specifications.
46GF Score
Get the complete analysis for SHSE:600080
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600080 has been successfully added to your 
